	US 12,268,710 B2
	Method of treating severe forms of pulmonary hypertension
Norbert F. Voelkel, Denver, CO (US); and Charles Magolske, Denver, CO (US)
Assigned to ReversPAH LLC, Denver, CO (US)
Filed by ReversPAH LLC, Denver, CO (US)
Filed on Jun. 24, 2020, as Appl. No. 16/910,447.
Claims priority of provisional application 62/866,781, filed on Jun. 26, 2019.
Prior Publication US 2020/0405748 A1, Dec. 31, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 33/02 (2006.01); A61K 33/04 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01)

CPC A61K 33/02 (2013.01) [A61K 33/04 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 45/06 (2013.01)]

13 Claims

1. A method of treating pulmonary arterial hypertension (PAH) in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a pharmaceutical composition comprising: a copper chelator comprising a tetrathiomolybdate salt; diethylcarbamazine (DEC); and a pharmaceutically acceptable carrier.